This San Francisco Lymphoma Rounds will now be a virtual program to deliver live professional education programming during the coronavirus (COVID-19) outbreak. This program will still provide a forum for local practicing physicians from academic and community medical centers to meet and address issues specific to the diagnosis and treatment of their lymphoma patients. You will be able to tune in over the phone or online.  Please continue to check this page for updates. For updates, please ensure you are subscribed to receive emails from the Lymphoma Research Foundation

For LRF’s official statement on COVID-19 and LRF programs and events, please click here.

Virtual Lymphoma Rounds: San Francisco

San Francisco, CA

Date:  Thursday, October 29, 2020
7:00 PM – 9:00 PM PT

VIRTUAL PROGRAM – This is a virtual Zoom event, accessible online and over the phone. Access instructions will be emailed after registration. If you are new to Zoom, learn more here: How-Do-I-Join-or-Test-My-Computer-Audio

ACTIVITY CO-CHAIRS

Charalambos Andreadis, MD
University of California, San Francisco

Michael Khodadoust, MD
Stanford University

Joseph Tuscano, MD
University of California, Davis

This program is free for healthcare professionals; however, pre-registration is required. Registration information below.

Please note: Only representatives from supporting pharmaceutical companies are invited to register. If your company is interested in becoming a Lymphoma Rounds supporter please contact Asalia Goldberg, LRF, at agoldberg@lymphoma.orgVirtual Exhibit opportunities are available.

Companies that have secured a national exhibit sponsorship for Lymphoma Rounds must still rsvp by emailing Asalia Goldberg (agoldberg@lymphoma.org) at least one week before the program to confirm their attendance.

To Register

VIRTUAL PROGRAM – This is a virtual Zoom event, accessible online and over the phone. Access instructions will be emailed after registration. If you are new to Zoom, learn more here: How-Do-I-Join-or-Test-My-Computer-Audio

ABOUT THE PROGRAM
The Lymphoma Rounds program provides a forum for local practicing physicians from academic and community medical centers to meet on a regular basis and address issues specific to the diagnosis and treatment of their lymphoma patients. Physicians share best practices and learn the latest information on new therapies and advances in the management of lymphoma through interactive case studies presented by lymphoma experts in the local area.

At the conclusion of this educational activity, the participant should be better able to:

  • Summarize the latest developments in lymphoma diagnosis, treatment and management.
  • Apply best practices for treating lymphoma patients.
  • Inform patients about potential clinical trial opportunities.
  • Establish a network of health care professionals who work with lymphoma patients.

San Francisco Lymphoma Rounds Steering Committee

University of California, Davis
Joseph Tuscano, MD
University of California, San Francisco
Charalambos Andreadis, MD
Stanford University Medical Center
Michael Khodadoust, MD (Chair)
Matthew Frank, MD, PhD

Joint Providership Statement

This activity has been planned and implemented in accordance with the Accreditation Requirements and Policies of the Accreditation Council for Continuing Medical Education through the joint providership of the University of Nebraska Medical Center, Center for Continuing Education and the Lymphoma Research Foundation.

Accreditation Statement

The University of Nebraska Medical Center, Center for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Statement

The University of Nebraska Medical Center, Center for Continuing Education designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credit (s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Sponsors
Lymphoma Research Foundation and the University of Nebraska Medical Center, Center for Continuing Education

This activity is supported by educational grants from:
AstraZeneca, Bristol Myers Squibb, BTG International, Inc., Karyopharm Therapeutics, Kite Pharma, a Gilead Company, Pharmacyclics LLC, an AbbVie Company and Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC; SeaGen and TG Therapeutics, Inc.